Charles Schwab’s Aptinyx Inc. Common Stock APTX Stock Holding History

Charles Schwab’s Portfolio APTX Stock Details APTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,000	Closed	-$46K	–	3694
2022 Q1	$46K	Hold	20,000	–	–	﹤0.01%	3540
2021 Q4	$54K	Buy	+20,000	New	+$48.1K	﹤0.01%	3508
2021 Q3	–	Sell	-17,590	Closed	-$50K	–	3562
2021 Q2	$50K	Sell	17,590 -71,316	-80%	-$199K	﹤0.01%	3370
2021 Q1	$267K	Hold	88,906	–	–	﹤0.01%	3272
2020 Q4	$308K	Buy	88,906 +18,405	+26%	+$64.1K	﹤0.01%	3152
2020 Q3	$239K	Hold	70,501	–	–	﹤0.01%	3125
2020 Q2	$294K	Buy	+70,501	New	+$239K	﹤0.01%	3057
2019 Q3	–	Sell	-21,352	Closed	-$72K	–	3199
2019 Q2	$72K	Sell	21,352 -29,946	-58%	-$106K	﹤0.01%	3135
2019 Q1	$208K	Buy	51,298 +814	+2%	+$5.9K	﹤0.01%	3016
2018 Q4	$836K	Sell	50,484 -360	-0.7%	-$8.52K	﹤0.01%	2594
2018 Q3	$1.47M	Buy	+50,844	New	+$1.24M	﹤0.01%	2515

Other funds holding APTX

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Charles Schwab's APTX Position: Q2 2022 in Review

Charles Schwab sold out of Aptinyx Inc. Common Stock (APTX) in Q2 2022, closing a stake of 20,000 shares — an estimated $46K sold.

Charles Schwab first reported a position in APTX in Q3 2018 and held it in 11 quarters. The position peaked at $1.47M in Q3 2018. 41 funds tracked by Wall St. Rank hold APTX as of Q2 2022.

Charles Schwab reported no remaining Aptinyx Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Charles Schwab sold 20,000 Aptinyx Inc. Common Stock shares in Q2 2022, an estimated $46K.
Charles Schwab first reported a position in Aptinyx Inc. Common Stock in Q3 2018 and held it in 11 quarters.
Charles Schwab's Aptinyx Inc. Common Stock position peaked at $1.47M in Q3 2018.
41 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.